Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: Etiologic significance of p53 and Ki-67 in non-tumorous epithelium

Journal of Oral Pathology and Medicine

Volumn 37, Issue 9, 2008, Pages 549-554

  Farshadpour, F ^a   Hordijk, G J ^a   Koole, R ^a   Slootweg, P J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Alcohol; Head and neck cancer; Ki 67; p53; Tobacco

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CIGARETTE SMOKING; CONTROLLED STUDY; DRINKING BEHAVIOR; EPITHELIUM; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; RISK FACTORS; SMOKING; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 51349154586     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00657.x     Document Type: Article

References (26)

1. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988 48 : 3282 7.
2. La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncol 1997 33 : 302 12.
3. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer 1995 75 (Suppl. 1 147 53.
4. Agudelo D, Quer M, Leon X, Diez S, Burgues J. Laryngeal carcinoma in patients without a history of tobacco and alcohol use. Head Neck 1997 19 : 200 4.
5. Constantinides MS, Rothstein SG, Persky MS. Squamous cell carcinoma in older patients without risk factors. Otolaryngol Head Neck Surg 1992 106 : 275 7.
6. Farshadpour F, Hordijk GJ, Koole R, Slootweg PJ. Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis 2007 13 : 239 43.
7. Wiseman SM, Swede H, Stoler DL, et al. Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol 2003 10 : 551 7.
8. Tabor MP, Brakenhoff RH, van Houten VM, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001 7 : 1523 32.
9. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993 53 : 4477 80.
10. Kropveld A, Rozemuller EH, Leppers FG, et al. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest 1999 79 : 347 53.
11. van Houten VM, Tabor MP, van den Brekel MW, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002 198 : 476 86.
12. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995 332 : 712 7.
13. Cruz IB, Meijer CJ, Snijders PJ, Snow GB, Walboomers JM, van der Waal I. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management. J Pathol 2000 191 : 132 7.
14. Gonzalez-Moles MA, Galindo P, Gutierrez J, Rodriguez-Archilla A, Ruiz-Avila I, Sanchez-Fernandez E. Significance of p53 expression in non-tumoral epithelium adjacent to oral squamous cell carcinomas. J Laryngol Otol 2002 116 : 355 8.
15. van Oijen MG, van de Craats JG, Slootweg PJ. p53 overexpression in oral mucosa in relation to smoking. J Pathol 1999 187 : 469 74.
16. Roland NJ, Caslin AW, Bowie GL, Jones AS. Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol Allied Sci 1994 19 : 13 8.
17. van Oijen MG, Gilsing MM, Rijksen G, Hordijk GJ, Slootweg PJ. Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol 1998 34 : 297 303.
18. Liu SC, Klein-Szanto AJ. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol 2000 36 : 145 51.
19. Macluskey M, Chandrachud LM, Pazouki S, et al. Apoptosis, proliferation, and angiogenesis in oral tissues. Possible relevance to tumour progression. J Pathol 2000 191 : 368 75.
20. Tabor MP, Braakhuis BJ, van der Wal JE, et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol 2003 199 : 354 60.
21. van Oijen MG, Medema RH, Slootweg PJ, Rijksen G. Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol 1998 110 : 24 31.
22. Warren S, Gates O. Multiple primary malignant tumors. A survey of the literature and a statistical study. Am J Cancer 1932 16 : 1358 414.
23. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993 328 : 184 94.
24. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999 109 : 1544 51.
25. Ogden GR, Chisholm DM, Morris AM, Stevenson JH. Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. J Pathol 1997 182 : 180 4.
26. Cruz IB, Snijders PJ, Meijer CJ, et al. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 1998 184 : 360 8.